Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Sep 25;69(10):e6910EDI.
doi: 10.1590/1806-9282.6910EDI. eCollection 2023.

Breast cancer survivals and hormone therapy: estrogen and melatonin

Affiliations
Editorial

Breast cancer survivals and hormone therapy: estrogen and melatonin

José Maria Soares Júnior et al. Rev Assoc Med Bras (1992). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: the authors declare there is no conflicts of interest.

References

    1. Soares JM, Júnior, Sorpreso IC, Baracat EC. Is hormone therapy during climacteric for all?. Rev Assoc Med Bras (1992). 2015;61(3):191–2. doi: 10.1590/1806-9282.61.03.191. - DOI - PubMed
    1. Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers (Basel). 2021;13(17):4287. doi: 10.3390/cancers13174287. - DOI - PMC - PubMed
    1. S A, Filho, Soares JM, Júnior, Arkader J, Maciel GA, Baracat EC. Attitudes and practices about postmenopausal hormone therapy among female gynecologists in Brazil. Maturitas. 2005;51(2):146–53. doi: 10.1016/j.maturitas.2004.06.018. - DOI - PubMed
    1. Sorpreso IC, Soares JM, Júnior, Fonseca AM, Baracat EC. Female aging. Rev Assoc Med Bras (1992). 2015;61(6):553–6. doi: 10.1590/1806-9282.61.06.553. - DOI - PubMed
    1. Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, et al. Prior hormone therapy and breast cancer risk in the women’s health Initiative randomized trial of estrogen plus progestin. Maturitas. 2006;55(2):103–15. doi: 10.1016/j.maturitas.2006.05.004. - DOI - PubMed

Publication types